Skip to the chapter telehealth peptide care A little room for better questions. Open the chapter index Introduction Before choosing care Chapter one The word “peptide” Chapter two An online visit Chapter three People and pharmacies Chapter four Questions to bring Chapter five The whole cost Chapter six Insurance and payment Chapter seven Reasons to pause Chapter eight Follow a source Introduction The word “peptide” Chapter one · The reading path # What does the name actually tell you? It helps to name the medicine before weighing a claim about it. ## Begin with the exact name Have you been given a medicine’s name, or only the phrase “peptide therapy”? Ask for its written name and whether the offer concerns an injection, a tablet or another form. Peptide describes a chain made from amino acids—the pieces that form proteins. US rules checked on September 26, 2026 do not treat everything called “peptide therapy” alike. To check whether supplying it is legal, you need to know the exact product and how it reaches the patient. A word beside the page Active ingredient The ingredient intended to do the work within the medicine. ## Which description fits the medicine in front of you? Semaglutide (Ozempic, Wegovy) is an example of a peptide with FDA-approved medicines, as of September 26, 2026. The abbreviation FDA refers here to the US Food and Drug Administration. Ask which exact product and use a claim refers to. With compounding, a doctor or pharmacist prepares or changes a drug to meet a particular need. Compounded medicines reach the market without an FDA check of their quality, benefits or harms. As of September 26, 2026, these medicines had no FDA approval. Compounding is sometimes legal, and it may serve a medical need that the available approved medicines cannot meet. An approved medicine Which product and which use? A compounded preparation What need calls for a change? A research label Why is this being offered as care? Different descriptions call for different questions. A word beside the page FDA approval Approval concerns a particular medicine and a named use; it does not approve every product with the same ingredient. ## Ask why a research product is being offered as treatment In letters issued in 2026, FDA alleged that products advertised for human use were unapproved drugs despite labels reserving them for research. Those letters set out enforcement allegations against particular firms, not court judgments. A useful question is: “Which actual medicine are we talking about, and what supports using it for my concern?” A word beside the page A product’s status Under US rules checked September 26, 2026, knowing an ingredient’s name is not enough to tell whether a product is legal to supply. Open the evidence behind these distinctions The consumer compounding pages explain why a compounded product and an approved product need different questions. FDA — compounding questions FDA — problems to understand with compounded drugs FDA — semaglutide (Wegovy) product label How to read these sources Read on · Chapter two An online visit ← Back to before choosing care Keep this guide beside your questions; these pages offer neither clinic services nor medicines. Read this chapter as text Text index Back to the chapter top ↑